Literature DB >> 24746921

Structure and function of the ARH family of ADP-ribosyl-acceptor hydrolases.

Masato Mashimo1, Jiro Kato1, Joel Moss2.   

Abstract

ADP-ribosylation is a post-translational protein modification, in which ADP-ribose is transferred from nicotinamide adenine dinucleotide (NAD(+)) to specific acceptors, thereby altering their activities. The ADP-ribose transfer reactions are divided into mono- and poly-(ADP-ribosyl)ation. Cellular ADP-ribosylation levels are tightly regulated by enzymes that transfer ADP-ribose to acceptor proteins (e.g., ADP-ribosyltransferases, poly-(ADP-ribose) polymerases (PARP)) and those that cleave the linkage between ADP-ribose and acceptor (e.g., ADP-ribosyl-acceptor hydrolases (ARH), poly-(ADP-ribose) glycohydrolases (PARG)), thereby constituting an ADP-ribosylation cycle. This review summarizes current findings related to the ARH family of proteins. This family comprises three members (ARH1-3) with similar size (39kDa) and amino acid sequence. ARH1 catalyzes the hydrolysis of the N-glycosidic bond of mono-(ADP-ribosyl)ated arginine. ARH3 hydrolyzes poly-(ADP-ribose) (PAR) and O-acetyl-ADP-ribose. The different substrate specificities of ARH1 and ARH3 contribute to their unique roles in the cell. Based on a phenotype analysis of ARH1(-/-) and ARH3(-/-) mice, ARH1 is involved in the action by bacterial toxins as well as in tumorigenesis. ARH3 participates in the degradation of PAR that is synthesized by PARP1 in response to oxidative stress-induced DNA damage; this hydrolytic reaction suppresses PAR-mediated cell death, a pathway termed parthanatos.
Copyright © 2014. Published by Elsevier B.V.

Entities:  

Keywords:  ADP-ribose-acceptor hydrolase; ADP-ribosylation; ARH; Cholera toxin; Parthanatos; Tumorigenesis

Mesh:

Substances:

Year:  2014        PMID: 24746921      PMCID: PMC4241382          DOI: 10.1016/j.dnarep.2014.03.005

Source DB:  PubMed          Journal:  DNA Repair (Amst)        ISSN: 1568-7856


  102 in total

1.  Poly(ADP-ribose) (PAR) polymer is a death signal.

Authors:  Shaida A Andrabi; No Soo Kim; Seong-Woon Yu; Hongmin Wang; David W Koh; Masayuki Sasaki; Judith A Klaus; Takashi Otsuka; Zhizheng Zhang; Raymond C Koehler; Patricia D Hurn; Guy G Poirier; Valina L Dawson; Ted M Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-20       Impact factor: 11.205

2.  Splicing regulates NAD metabolite binding to histone macroH2A.

Authors:  Georg Kustatscher; Michael Hothorn; Céline Pugieux; Klaus Scheffzek; Andreas G Ladurner
Journal:  Nat Struct Mol Biol       Date:  2005-06-19       Impact factor: 15.369

Review 3.  Glycosylphosphatidylinositol-anchored and secretory isoforms of mono-ADP-ribosyltransferases.

Authors:  I J Okazaki; J Moss
Journal:  J Biol Chem       Date:  1998-09-11       Impact factor: 5.157

4.  Identification of critical, conserved vicinal aspartate residues in mammalian and bacterial ADP-ribosylarginine hydrolases.

Authors:  P Konczalik; J Moss
Journal:  J Biol Chem       Date:  1999-06-11       Impact factor: 5.157

5.  NAD: arginine mono-ADP-ribosyltransferases from animal cells.

Authors:  J Moss; M Vaughan
Journal:  Methods Enzymol       Date:  1984       Impact factor: 1.600

6.  PARP-2, A novel mammalian DNA damage-dependent poly(ADP-ribose) polymerase.

Authors:  J C Amé; V Rolli; V Schreiber; C Niedergang; F Apiou; P Decker; S Muller; T Höger; J Ménissier-de Murcia; G de Murcia
Journal:  J Biol Chem       Date:  1999-06-18       Impact factor: 5.157

Review 7.  Characterization of NAD:arginine ADP-ribosyltransferases.

Authors:  J Moss; E Balducci; E Cavanaugh; H J Kim; P Konczalik; E A Lesma; I J Okazaki; M Park; M Shoemaker; L A Stevens; A Zolkiewska
Journal:  Mol Cell Biochem       Date:  1999-03       Impact factor: 3.396

8.  Integrin alpha 7 as substrate for a glycosylphosphatidylinositol-anchored ADP-ribosyltransferase on the surface of skeletal muscle cells.

Authors:  A Zolkiewska; J Moss
Journal:  J Biol Chem       Date:  1993-12-05       Impact factor: 5.157

9.  A family of macrodomain proteins reverses cellular mono-ADP-ribosylation.

Authors:  Gytis Jankevicius; Markus Hassler; Barbara Golia; Vladimir Rybin; Martin Zacharias; Gyula Timinszky; Andreas G Ladurner
Journal:  Nat Struct Mol Biol       Date:  2013-03-10       Impact factor: 15.369

Review 10.  Macrodomain-containing proteins: regulating new intracellular functions of mono(ADP-ribosyl)ation.

Authors:  Karla L H Feijs; Alexandra H Forst; Patricia Verheugd; Bernhard Lüscher
Journal:  Nat Rev Mol Cell Biol       Date:  2013-06-05       Impact factor: 94.444

View more
  35 in total

1.  Bi-allelic ADPRHL2 Mutations Cause Neurodegeneration with Developmental Delay, Ataxia, and Axonal Neuropathy.

Authors:  Katharina Danhauser; Bader Alhaddad; Christine Makowski; Dorota Piekutowska-Abramczuk; Steffen Syrbe; Natalia Gomez-Ospina; Melanie A Manning; Anna Kostera-Pruszczyk; Claudia Krahn-Peper; Riccardo Berutti; Reka Kovács-Nagy; Mirjana Gusic; Elisabeth Graf; Lucia Laugwitz; Michaela Röblitz; Andreas Wroblewski; Hans Hartmann; Anibh M Das; Eva Bültmann; Fang Fang; Manting Xu; Ulrich A Schatz; Daniela Karall; Herta Zellner; Edda Haberlandt; René G Feichtinger; Johannes A Mayr; Thomas Meitinger; Holger Prokisch; Tim M Strom; Rafał Płoski; Georg F Hoffmann; Maciej Pronicki; Penelope E Bonnen; Susanne Morlot; Tobias B Haack
Journal:  Am J Hum Genet       Date:  2018-10-25       Impact factor: 11.025

2.  Defective heart chamber growth and myofibrillogenesis after knockout of adprhl1 gene function by targeted disruption of the ancestral catalytic active site.

Authors:  Stuart J Smith; Norma Towers; Kim Demetriou; Timothy J Mohun
Journal:  PLoS One       Date:  2020-07-29       Impact factor: 3.240

Review 3.  Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseases.

Authors:  Nathan A Berger; Valerie C Besson; A Hamid Boulares; Alexander Bürkle; Alberto Chiarugi; Robert S Clark; Nicola J Curtin; Salvatore Cuzzocrea; Ted M Dawson; Valina L Dawson; György Haskó; Lucas Liaudet; Flavio Moroni; Pál Pacher; Peter Radermacher; Andrew L Salzman; Solomon H Snyder; Francisco Garcia Soriano; Robert P Strosznajder; Balázs Sümegi; Raymond A Swanson; Csaba Szabo
Journal:  Br J Pharmacol       Date:  2017-03-26       Impact factor: 8.739

4.  Monitoring Poly(ADP-ribosyl)glycohydrolase Activity with a Continuous Fluorescent Substrate.

Authors:  Bryon S Drown; Tomohiro Shirai; Johannes Gregor Matthias Rack; Ivan Ahel; Paul J Hergenrother
Journal:  Cell Chem Biol       Date:  2018-10-11       Impact factor: 8.116

5.  PARP1 inhibition alleviates injury in ARH3-deficient mice and human cells.

Authors:  Masato Mashimo; Xiangning Bu; Kazumasa Aoyama; Jiro Kato; Hiroko Ishiwata-Endo; Linda A Stevens; Atsushi Kasamatsu; Lynne A Wolfe; Camilo Toro; David Adams; Thomas Markello; William A Gahl; Joel Moss
Journal:  JCI Insight       Date:  2019-02-21

Review 6.  Emerging roles of ADP-ribosyl-acceptor hydrolases (ARHs) in tumorigenesis and cell death pathways.

Authors:  Xiangning Bu; Jiro Kato; Joel Moss
Journal:  Biochem Pharmacol       Date:  2018-09-27       Impact factor: 5.858

7.  Q-FADD: A Mechanistic Approach for Modeling the Accumulation of Proteins at Sites of DNA Damage.

Authors:  Jyothi Mahadevan; Johannes Rudolph; Asmita Jha; Jian Wei Tay; Joseph Dragavon; Erik M Grumstrup; Karolin Luger
Journal:  Biophys J       Date:  2019-05-03       Impact factor: 4.033

8.  Viral Macro Domains Reverse Protein ADP-Ribosylation.

Authors:  Changqing Li; Yannick Debing; Gytis Jankevicius; Johan Neyts; Ivan Ahel; Bruno Coutard; Bruno Canard
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

9.  AI26 inhibits the ADP-ribosylhydrolase ARH3 and suppresses DNA damage repair.

Authors:  Xiuhua Liu; Rong Xie; Lily L Yu; Shih-Hsun Chen; Xiaoyun Yang; Anup K Singh; Hongzhi Li; Chen Wu; Xiaochun Yu
Journal:  J Biol Chem       Date:  2020-08-04       Impact factor: 5.157

Review 10.  Functional Role of ADP-Ribosyl-Acceptor Hydrolase 3 in poly(ADP-Ribose) Polymerase-1 Response to Oxidative Stress.

Authors:  Masato Mashimo; Joel Moss
Journal:  Curr Protein Pept Sci       Date:  2016       Impact factor: 3.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.